BACKGROUND: Reports on the effect of HIV-1 infection on healing rates of ulcers are conflicting. GOAL: The goal was to determine the etiology and response to treatment of genital ulcer disease (GUD) in relation to HIV-1 infection. STUDY DESIGN: This was a cohort study of patients with GUD treated with local syndromic management protocols. RESULTS: Among the 587 recruited, the prevalences of infections due to HSV, Treponema pallidum, Chlamydia trachomatis (lymphogranuloma venereum [LGV]), Haemophilus ducreyi, Calymmatobacterium granulomatis, and HIV-1 were 48%, 14%, 11%, 10%, 1%, and 75%, respectively. The prevalence T. pallidum of was higher among men (P = 0.03), and an association was seen among HIV-1-seronegatives on univariate and multivariate analyses (P < 0.001; = 0.01). The prevalence of C trachomatis (LGV) was higher among females (P = 0.004), and an association was seen among HIV-1-seropositives on univariate analysis (P = 0.04). At follow-up, 40/407 (10%) showed a decreased healing tendency, not associated with ulcer etiology or HIV-1 seropositivity. CONCLUSION: Response to syndromic management of GUD was acceptable and not associated with HIV-1 coinfection.
BACKGROUND: Reports on the effect of HIV-1 infection on healing rates of ulcers are conflicting. GOAL: The goal was to determine the etiology and response to treatment of genital ulcer disease (GUD) in relation to HIV-1 infection. STUDY DESIGN: This was a cohort study of patients with GUD treated with local syndromic management protocols. RESULTS: Among the 587 recruited, the prevalences of infections due to HSV, Treponema pallidum, Chlamydia trachomatis (lymphogranuloma venereum [LGV]), Haemophilus ducreyi, Calymmatobacterium granulomatis, and HIV-1 were 48%, 14%, 11%, 10%, 1%, and 75%, respectively. The prevalence T. pallidum of was higher among men (P = 0.03), and an association was seen among HIV-1-seronegatives on univariate and multivariate analyses (P < 0.001; = 0.01). The prevalence of C trachomatis (LGV) was higher among females (P = 0.004), and an association was seen among HIV-1-seropositives on univariate analysis (P = 0.04). At follow-up, 40/407 (10%) showed a decreased healing tendency, not associated with ulcer etiology or HIV-1 seropositivity. CONCLUSION: Response to syndromic management of GUD was acceptable and not associated with HIV-1 coinfection.
Authors: J M Pickering; J A G Whitworth; P Hughes; M Kasse; D Morgan; B Mayanja; L Van der Paal; P Mayaud Journal: Sex Transm Infect Date: 2005-12 Impact factor: 3.519
Authors: Supriya D Mehta; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; Robert C Bailey Journal: AIDS Date: 2012-06-01 Impact factor: 4.177
Authors: Patrick D J Sturm; Prashini Moodley; Keshnie Govender; Louise Bohlken; Trusha Vanmali; A Willem Sturm Journal: J Clin Microbiol Date: 2005-06 Impact factor: 5.948
Authors: Koleka Mlisana; Nivashnee Naicker; Lise Werner; Lindi Roberts; Francois van Loggerenberg; Cheryl Baxter; Jo-Ann S Passmore; Anneke C Grobler; A Willem Sturm; Carolyn Williamson; Katharina Ronacher; Gerhard Walzl; Salim S Abdool Karim Journal: J Infect Dis Date: 2012-04-19 Impact factor: 5.226
Authors: Gabriele Riedner; Jim Todd; Mary Rusizoka; Donan Mmbando; Leonard Maboko; Eligius Lyamuya; Oliver Hoffmann; I MacLean; Heiner Grosskurth; Richard Hayes Journal: Sex Transm Infect Date: 2006-09-13 Impact factor: 3.519